Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 736 | 227 | -14,087 | -13,045 | -11,437 |
| Depreciation Amortization | 1,183 | 630 | 2,375 | -6 | -14 |
| Accounts receivable | -2,882 | -1,585 | -11,649 | -4,120 | 6,482 |
| Accounts payable and accrued liabilities | -213 | -524 | 11,653 | 2,962 | -1,343 |
| Other Working Capital | -6,046 | -5,430 | -1,330 | 2,122 | 10,853 |
| Other Operating Activity | 3,825 | 2,465 | 678 | 1,950 | -4,385 |
| Operating Cash Flow | $-3,397 | $-4,217 | $-12,360 | $-10,137 | $156 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | N/A | -8 | -6 | -6 |
| Investing Cash Flow | $-23 | $N/A | $-8 | $-6 | $-6 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -73 | -37 | -67 | -30 | -73 |
| Common Stock Issued | N/A | 0 | 14,415 | 14,414 | 6,845 |
| Financing Cash Flow | $-73 | $-37 | $14,348 | $14,384 | $6,772 |
| Beginning Cash Position | 13,213 | 13,213 | 11,233 | 11,233 | 11,233 |
| End Cash Position | 9,720 | 8,959 | 13,213 | 15,474 | 18,155 |
| Net Cash Flow | $-3,493 | $-4,254 | $1,980 | $4,241 | $6,922 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,397 | -4,217 | -12,360 | -10,137 | 156 |
| Capital Expenditure | -23 | N/A | -8 | -6 | -6 |
| Free Cash Flow | -3,420 | -4,217 | -12,368 | -10,143 | 150 |